Stock Watch - 10Dec2024A high risk and beaten down stock to watch. Not ready for entry yet.
Possible entry at 90 cents
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.7005 USD
−37.34 M USD
0.00 USD
69.73 M
About SELLAS Life Sciences Group, Inc.
Sector
CEO
Angelos M. Stergiou
Headquarters
New York
Website
Founded
2006
FIGI
BBG000VC77H7
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
SLS OversoldSLS was sold off hard the last two days despite positive news. The current price has acted as both support and resistance in recent months (shaded area).
With an RSI of 38 and the price well bellow the POC line (90 days) I think 9.08 may have been the bottom. I think the drop had more to do with l
SLS BullishToday's candle took out two fibonacci levels to close above the .38 fib level. The set up resembles a jacked up cup and handle. After a healthy retracement from its recent high I am looking for a move up the fibonacci scale.
target: 11.85, 12.19, 12,70, 13.35
short term +6,000%SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States.
SLSSellas Life Sciences Group Inc (NASDAQ:SLS) After a solid breakout on rising volume SLS has pulled back to support near $9 and should set up for its next upside move. Things are now beginning to turn in favor of the Bulls. The MACD confirms the recent jump and daily RSI also shows that there's more
SLSThis is an incredible long opportunity, the stock shows huge institutional interest, while also being hugely oversold, combined with the recent breakout. this is exactly what I have been waiting for, this has an outstanding risk to reward ratio.
Why SELLAS Life Sciences Is Surging Premarket?Why SELLAS Life Sciences Is Surging Premarket?
SELLAS Life Sciences is captivating investors thanks to its late-stage cancer vaccine
Thanks to some news in December in the biopharma space, SLS stock is racing higher. So what was that news? And what else do you need to know?
its leading candidate
Sellas breakout in the next few days Looks like we will get some more movement in the next few days. Hope we can hold the support at 5.50 and follow the trendline that was started a month ago before the spike
Spike is not likely, but long-term looks like bullish.Great resistance at 7$, with low volume. It looks like it won't go under 7$ again for a while. SLS entered into a share purchase agreement with institutional investors! 7$ per share.Total 16.2 Million $. Once the registered direct offering is closed (yesterday or today? im not sure), I think we will
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SLS is 0.8880 USD — it has decreased by −1.11% in the past 24 hours. Watch SELLAS Life Sciences Group, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange SELLAS Life Sciences Group, Inc. stocks are traded under the ticker SLS.
SLS stock has risen by 3.26% compared to the previous week, the month change is a −33.23% fall, over the last year SELLAS Life Sciences Group, Inc. has showed a −28.96% decrease.
We've gathered analysts' opinions on SELLAS Life Sciences Group, Inc. future price: according to them, SLS price has a max estimate of 7.50 USD and a min estimate of 4.00 USD. Watch SLS chart and read a more detailed SELLAS Life Sciences Group, Inc. stock forecast: see what analysts think of SELLAS Life Sciences Group, Inc. and suggest that you do with its stocks.
SLS stock is 6.85% volatile and has beta coefficient of 0.99. Track SELLAS Life Sciences Group, Inc. stock price on the chart and check out the list of the most volatile stocks — is SELLAS Life Sciences Group, Inc. there?
Today SELLAS Life Sciences Group, Inc. has the market capitalization of 62.50 M, it has decreased by −1.54% over the last week.
Yes, you can track SELLAS Life Sciences Group, Inc. financials in yearly and quarterly reports right on TradingView.
SELLAS Life Sciences Group, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
SLS earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.13 USD resulting in a 21.05% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about SELLAS Life Sciences Group, Inc. earnings.
SELLAS Life Sciences Group, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SLS net income for the last quarter is −7.11 M USD, while the quarter before that showed −7.47 M USD of net income which accounts for 4.85% change. Track more SELLAS Life Sciences Group, Inc. financial stats to get the full picture.
No, SLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 16.00 employees. See our rating of the largest employees — is SELLAS Life Sciences Group, Inc. on this list?
Like other stocks, SLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SELLAS Life Sciences Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SELLAS Life Sciences Group, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SELLAS Life Sciences Group, Inc. stock shows the sell signal. See more of SELLAS Life Sciences Group, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.